Regentis Biomaterials Ltd. Product Pipeline Analysis

Abstract

Regentis Biomaterials Ltd. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Scope' s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

* Details of development stage by sector and equipment type.
* Pipeline products grouped by therapy area, development stage and trial phase.
* Detailed information on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results.
* Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
* Product updates covering estimated approval dates and estimated launch dates.
* Descriptions of novel technologies relating to pipeline products of the company.
* Patents and patent applications covered for the product.
* News updates on key events relating to the product and its development.

Reasons to buy

* A single source to fulfill competitor information relating to products in development.
* Identify pipeline products that are potential competitor to your product lines.
* Understand a company' s strategic position by accessing detailed independent intelligence on its product pipeline.
* Access clinical trial information to map trial results and plan targeted marketing activities.
* Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
* Identification of potential investment opportunities.
* Build up knowledge base for potential distribution and marketing partners.
* Helps avoid patent infringement.
* Timelines from concept to market lets you keep track of market potential build for a new product.
* Assess a company' s future growth by determining its pipeline depth, for probable acquisition opportunities.